🔗 Share this article

Treasury head Rachel Reeves has announced she is planning "targeted action to deal with household expense issues" in the forthcoming financial statement.

Speaking to media outlets, she emphasized that reducing price rises is a collective duty of both the administration and the Bank of England.

The United Kingdom's inflation rate is projected to be the highest among the Group of Seven developed nations this year and next.

Possible Utility Cost Measures

Reports indicate the government could intervene to lower energy bills, for example by reducing the present 5% rate of value-added tax charged on energy supplies.

An additional approach is to cut some of the regulatory levies presently added to bills.

Fiscal Constraints and Analyst Predictions

The government will receive the next report from the official forecaster, the OBR, on the start of the week, which will clarify how much scope there is for such measures.

The expectation from most experts is that the Chancellor will have to announce higher taxes or spending cuts in order to adhere to her voluntary debt limits.

Previously on Thursday, calculations suggested there was a £22bn gap for the Treasury chief to fill, which is at the more modest range of expectations.

"It is a collective job between the Bank of England and the administration to bear down further on some of the causes of price increases," Reeves told the BBC in Washington, at the yearly gatherings of the International Monetary Fund and global financial institution.

Tax Pledges and International Concerns

While much of the focus has been on expected tax rises, the chancellor said the latest data from the fiscal watchdog had not changed her vow to campaign commitments not to increase tax levels on income tax, VAT or National Insurance.

She attributed an "unpredictable global environment" with increasing international and trade concerns for the Budget tax moves, probably to be targeted on those "wealthiest."

International Economic Disputes

Referring to concerns about the UK's trade ties with China she said: "The UK's national security always are paramount."

Last week's announcement by Chinese authorities to tighten export controls on critical minerals and other resources that are essential for high-technology production led US President the US President to suggest an extra 100% import tax on imports from China, raising the prospect of an all-out commercial conflict between the two economic giants.

The American finance chief described China's decision "commercial pressure" and "a global supply chain power grab."

Asked about considering the US offer to participate in its dispute with China, the Chancellor said she was "extremely troubled" by China's measures and urged the Chinese government "not to put up barriers and restrict access."

She said the action was "harmful for the global economy and creates further challenges."

"In my view there are areas where we must challenge China, but there are also valuable prospects to export to Chinese markets, including banking sector and other sectors of the economic system. We've got to achieve that balance appropriate."

The chancellor also confirmed she was collaborating with G7 counterparts "regarding our own essential resources plan, so that we are more independent."

NHS Medicine Costs and Investment

The Chancellor also recognized that the cost the NHS spends on medicines could increase as a consequence of ongoing talks with the Trump administration and its drugs companies, in exchange for reduced taxes and funding.

A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either pausing or scrapping investments in the United Kingdom, with some attributing the low prices they are receiving.

Recently, the Science Minister said the cost the health service pays for medicines would have to increase to halt businesses and pharmaceutical investment departing from the UK.

Reeves told media: "It has been observed because of the pricing regime, that drug testing, recent pharmaceuticals have not been available in the United Kingdom in the manner that they are in other EU nations."

"We want to guarantee that patients receiving treatment from the National Health Service are able to receive the top critical drugs in the globe. And so we are examining this situation, and... aiming to secure additional funding into the UK."